Cell-derived microparticles: new targets in the therapeutic management of disease.

Intercellular communication is essential to maintain vital physiological activities and to regulate the organism's phenotype. There are a number of ways in which cells communicate with one another. This can occur via autocrine signaling, endocrine signaling or by the transfer of molecular mediators across gap junctions. More recently communication via microvesicular shedding has gained important recognition as a significant pathway by which cells can coordinate the spread and dominance of selective traits within a population. Through this communication apparatus, cells can now acquire and secure a survival advantage, particularly in the context of malignant disease. This review aims to highlight some of the functions and implications of microparticles in physiology of various disease states, and present a novel therapeutic strategy through the regulation of microparticle production.

[1]  I. Vorobjev,et al.  Circulating microparticles: square the circle , 2013, BMC Cell Biology.

[2]  Penelope V Dalla,et al.  Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells , 2013, PloS one.

[3]  U. Wewer,et al.  Regulation of ROCK Activity in Cancer , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  F. Sánchez‐Madrid,et al.  Transfer of extracellular vesicles during immune cell‐cell interactions , 2013, Immunological reviews.

[5]  S. Chakraborti,et al.  Implications of calpains in health and diseases. , 2012, Indian journal of biochemistry & biophysics.

[6]  R. Cerione,et al.  R(h)oads to microvesicles , 2012, Small GTPases.

[7]  M. Simionescu,et al.  Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? , 2012, Journal of cellular and molecular medicine.

[8]  Frederick Luk,et al.  Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits , 2012, Molecular Cancer.

[9]  A. Guha,et al.  Extracellular vesicles – vehicles that spread cancer genes , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  A. Goette,et al.  Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation. , 2012, Cardiovascular therapeutics.

[11]  M. Bebawy,et al.  Microparticles and their emerging role in cancer multidrug resistance. , 2012, Cancer treatment reviews.

[12]  I. Fleming,et al.  All cut up! The consequences of calpain activation on platelet function. , 2012, Vascular pharmacology.

[13]  B. Cookson,et al.  Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial Life , 2012, Infection and Immunity.

[14]  J. Inal,et al.  Microvesicles in Health and Disease , 2012, Archivum Immunologiae et Therapiae Experimentalis.

[15]  G. Webb,et al.  Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-cell P-glycoprotein Transfers in MCF-7 Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[16]  M. Bebawy,et al.  Microparticle‐associated nucleic acids mediate trait dominance in cancer , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Lip,et al.  Circulating microparticles: new insights into the biochemical basis of microparticle release and activity , 2011, Basic Research in Cardiology.

[18]  G. Grau,et al.  Platelets and microparticles in cerebral malaria: the unusual suspects , 2011 .

[19]  György Nagy,et al.  Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2022 .

[20]  Neil O. Carragher,et al.  The calpain system and cancer , 2011, Nature Reviews Cancer.

[21]  I. Donkor Calpain inhibitors: a survey of compounds reported in the patent and scientific literature , 2011, Expert opinion on therapeutic patents.

[22]  D. Stirling,et al.  Microparticles, malignancy and thrombosis , 2011, British journal of haematology.

[23]  Jared L. Johnson,et al.  Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells , 2011, Proceedings of the National Academy of Sciences.

[24]  Françoise Dignat-George,et al.  The Many Faces of Endothelial Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Freyssinet,et al.  Cellular Mechanisms Underlying the Formation of Circulating Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[26]  G. Grau,et al.  Elevated Cell-Specific Microparticles Are a Biological Marker for Cerebral Dysfunctions in Human Severe Malaria , 2010, PloS one.

[27]  P. Brunet,et al.  Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis , 2010, Thrombosis and Haemostasis.

[28]  G. Grau,et al.  Microvesiculation and cell interactions at the brain–endothelial interface in cerebral malaria pathogenesis , 2010, Progress in Neurobiology.

[29]  J. Freyssinet,et al.  Formation of procoagulant microparticles and properties. , 2010, Thrombosis research.

[30]  Richard W. Farndale,et al.  Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.

[31]  G. Grau,et al.  Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells , 2009, Leukemia.

[32]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[33]  H R Büller,et al.  Cell-derived microvesicles and cancer. , 2009, The Netherlands journal of medicine.

[34]  Loïc Doeuvre,et al.  Cell‐derived microparticles: a new challenge in neuroscience , 2009, Journal of neurochemistry.

[35]  J. Rak,et al.  Microvesicles: Messengers and mediators of tumor progression , 2009, Cell cycle.

[36]  P. Fontana,et al.  Cell-derived microparticles in haemostasis and vascular medicine , 2009, Thrombosis and Haemostasis.

[37]  R. Campbell,et al.  Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin , 2008, Nature.

[38]  Lianbo Yu,et al.  Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.

[39]  B. Furie,et al.  Mechanisms of thrombus formation. , 2008, The New England journal of medicine.

[40]  C. Théry,et al.  Exosomes from Bronchoalveolar Fluid of Tolerized Mice Prevent Allergic Reaction1 , 2008, The Journal of Immunology.

[41]  H. Lage An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.

[42]  A. Tedgui,et al.  Role of microparticles in atherothrombosis , 2008, Journal of internal medicine.

[43]  Marie-France Penet,et al.  Protection against cerebral malaria by the low-molecular-weight thiol pantethine , 2008, Proceedings of the National Academy of Sciences.

[44]  J. Freyssinet,et al.  Platelet microparticles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses , 2008, Platelets.

[45]  E. Angles-cano,et al.  Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. , 2007, Blood.

[46]  Riitta Lahesmaa,et al.  Exosomes with Immune Modulatory Features Are Present in Human Breast Milk1 , 2007, The Journal of Immunology.

[47]  J. Liao,et al.  Rho Kinase (ROCK) Inhibitors , 2007, Journal of cardiovascular pharmacology.

[48]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[49]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[50]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.

[51]  H. Schultheiss,et al.  Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. , 2007, Cardiovascular research.

[52]  J. Auger,et al.  Thiosulfinates modulate platelet activation by reaction with surface free sulfhydryls and internal thiol-containing proteins , 2007, Platelets.

[53]  J. Nolan,et al.  A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. , 2006, Trends in parasitology.

[54]  B. Loriod,et al.  Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. , 2006, Blood.

[55]  G. Grau,et al.  Cell vesiculation and immunopathology: implications in cerebral malaria. , 2006, Microbes and infection.

[56]  Masayuki Nakamura,et al.  Exploration of orally available calpain inhibitors 2: peptidyl hemiacetal derivatives. , 2006, Journal of medicinal chemistry.

[57]  N. Carragher Calpain inhibition: a therapeutic strategy targeting multiple disease states. , 2006, Current pharmaceutical design.

[58]  D. Pisetsky,et al.  Microparticles as mediators of cellular cross-talk in inflammatory disease , 2006, Autoimmunity.

[59]  B. Furie,et al.  Thrombus formation in vivo. , 2005, The Journal of clinical investigation.

[60]  Z. Fishelson,et al.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer , 2005, Springer Seminars in Immunopathology.

[61]  L. Schofield,et al.  Immunological processes in malaria pathogenesis , 2005, Nature Reviews Immunology.

[62]  T. Iwasaka,et al.  Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus , 2005, Journal of Human Hypertension.

[63]  Graça Raposo,et al.  Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.

[64]  P. Comfurius,et al.  Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.

[65]  K. Fukudome,et al.  Activated protein C induces the release of microparticle-associated endothelial protein C receptor. , 2005, Blood.

[66]  Andre Levchenko,et al.  Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Freyssinet,et al.  Membrane microparticles: two sides of the coin. , 2005, Physiology.

[68]  M. Hristov,et al.  Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. , 2004, Blood.

[69]  D. Fishman,et al.  Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles , 2004, Cancer Research.

[70]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  N. Takahashi,et al.  Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. , 2004, Atherosclerosis.

[72]  J. Freyssinet,et al.  Cellular microparticles: a disseminated storage pool of bioactive vascular effectors , 2004, Current opinion in hematology.

[73]  T. Iwasaka,et al.  Effect of Ticlopidine on Monocyte-derived Microparticles and Activated Platelet Markers in Diabetes Mellitus , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[74]  Hans-Hermann Gerdes,et al.  Nanotubular Highways for Intercellular Organelle Transport , 2004, Science.

[75]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[76]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[77]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[78]  J. Freyssinet Cellular microparticles: what are they bad or good for? , 2003, Journal of thrombosis and haemostasis : JTH.

[79]  G. Lin,et al.  A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. , 2003, Journal of molecular biology.

[80]  K. Preissner,et al.  Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.

[82]  P. Yuen,et al.  Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor. , 2003, Journal of medicinal chemistry.

[83]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[84]  L. Zitvogel,et al.  Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.

[85]  N. Mohandas,et al.  Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[86]  L. Qin,et al.  Comparison of Pgp- and MRP-Mediated Multidrug Resistance in Leukemia Cell Lines , 2002, International journal of hematology.

[87]  J. Auger,et al.  Thiosulfinates Inhibit Platelet Aggregation and Microparticle Shedding at a Calpain-dependent Step , 2001, Thrombosis and Haemostasis.

[88]  V. Fadok,et al.  Apoptotic cell removal , 2001, Current Biology.

[89]  Lars Holmgren,et al.  Horizontal transfer of oncogenes by uptake of apoptotic bodies , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[90]  E. Sahai,et al.  Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.

[91]  I. Donkor A survey of calpain inhibitors. , 2000, Current medicinal chemistry.

[92]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[93]  D. Potter,et al.  Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading* , 1999, The Journal of Biological Chemistry.

[94]  J. Sixma,et al.  Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .

[95]  D. Dekkers,et al.  Lipid translocation across the plasma membrane of mammalian cells. , 1999, Biochimica et biophysica acta.

[96]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[97]  L. Holmgren,et al.  Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies , 1999, Vox sanguinis.

[98]  K. Suzuki,et al.  Structure and physiological function of calpains. , 1997, The Biochemical journal.

[99]  J. Freyssinet,et al.  The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide , 1997, British journal of haematology.

[100]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[101]  I. Pastan,et al.  P-glycoprotein and multidrug resistance. , 1996, Current opinion in genetics & development.

[102]  J. Powers,et al.  Novel Peptidyl α-Keto Amide Inhibitors of Calpains and Other Cysteine Proteases , 1996 .

[103]  E. Lunney,et al.  An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Freyssinet,et al.  Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. , 1995, Biochemistry.

[105]  P. Comfurius,et al.  Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. , 1994, Biochimica et biophysica acta.

[106]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[107]  L. Horstman,et al.  Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.

[108]  P. Sims,et al.  Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. , 1993, The Journal of biological chemistry.

[109]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[110]  M. Dietel,et al.  Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. , 1992, Biochemical pharmacology.

[111]  P. Tracy,et al.  Endotoxin enhances the expression of monocyte prothrombinase activity. , 1992, Blood.

[112]  C. C. Reynolds,et al.  Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. , 1991, The Journal of biological chemistry.

[113]  C. C. Reynolds,et al.  THE ROLE OF CALPAIN IN STIMULUS-RESPONSE COUPLING : EVIDENCE THAT CALPAIN MEDIATES AGONIST-INDUCED EXPRESSION OF PROCOAGULANT ACTIVITY IN PLATELETS , 1990 .

[114]  A. Schroit,et al.  Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. , 1990, Biochimica et biophysica acta.

[115]  V. Consalvi,et al.  Irreversible inactivation of papain and cathepsin B by epoxidic substrate analogues , 1990 .

[116]  J. Philippot,et al.  Asymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of guinea pig reticulocytes: Evidence precluding a role for “aminophospholipid translocase” , 1989, Journal of cellular physiology.

[117]  B. Kendler Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. , 1987, Preventive medicine.

[118]  Y. Ostchega,et al.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[119]  R. Ganapathi,et al.  Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells. , 1984, European journal of cancer & clinical oncology.

[120]  T. Adachi,et al.  Papain inhibitions by optically active E-64 analogs. , 1981, Journal of biochemistry.

[121]  T. Tsuruo,et al.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.

[122]  K. Hirschhorn,et al.  Observations on cell lines derived from a patient with Hodgkin's disease. , 1978, Cancer research.

[123]  P. Wolf The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[124]  D. Pisetsky,et al.  The role of microparticles in the pathogenesis of rheumatic diseases , 2010, Nature Reviews Rheumatology.

[125]  R. Andriantsitohaina,et al.  Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. , 2008, Physiological research.

[126]  Y. Ikeda,et al.  Function and role of microparticles in various clinical settings. , 2008, Thrombosis research.

[127]  F. Sharom ABC multidrug transporters: structure, function and role in chemoresistance. , 2008, Pharmacogenomics.

[128]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Endothelial cell-derived microparticles , 2007 .

[129]  T. Iwasaka,et al.  Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus , 2007, Journal of Human Hypertension.

[130]  E. Bouhassira,et al.  Congenital Factor V Deficiency Low Plasma Levels of Tissue Factor Pathway Inhibitor in Patients With , 2006 .

[131]  G. Grau,et al.  ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. , 2005, The American journal of pathology.

[132]  K. Nooter,et al.  Effects of verapamil on the pharmacokinetics of daunomycin in the rat , 2004, Cancer Chemotherapy and Pharmacology.

[133]  H. K. Kim,et al.  Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.

[134]  M. Gottesman Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[135]  G. Ossenkoppele,et al.  Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia , 1997 .

[136]  K. Imahori,et al.  Inhibition of epoxide derivatives on chicken calcium-activated neutral protease (CANP) in vitro and in vivo. , 1980, Journal of biochemistry.